Endometriosis

A study revealed that women with endometriosis are significantly more likely to develop mental health issues, including depression and anxiety.

Experts recommend early referral to specialized centers for adolescents with dysmenorrhea to ensure timely diagnosis and treatment of potential endometriosis, preventing disease progression and preserving fertility.

A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.

A recent study unveiled the sustained safety and efficacy of relugolix combination therapy over 2 years.

A recent study revealed that women with endometriosis not only face a mean delay of 7 to 11 years in diagnosis but also suffer from increased menstrual, mental health, and other pain symptoms, impacting their overall well-being and quality of life.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Findings and significance for gynecologic surgeons.

In a recent study, women with a history of dysmenorrhea were at a significantly increased risk of endometriosis.

In a recent study, a lower pain-related quality of life was found in patients with preoperative pelvic pain conditions after surgery.

In a recent study, providers were more likely to recommend combined hormone replacement therapy (HRT) than estrogen-only HRT in patients with severe endometriosis because of recurrence risks from estrogen-only HRT.

Reductions in symptom incidence and severity from uterine fibroids and endometriosis have been observed in patients receiving relugolix combination therapy.

In a recent study, the Deep Pelvic Endometriosis Index accurately predicted operating and hospital stay length, along with postoperative complications, in patients with deep pelvic endometriosis.

Pain mechanisms are multifactorial, complex, and still poorly understood.

A panel of experts provide an overview of choosing endometriosis treatment and how to discuss these options with patients.

A panel of experts provide an overview of GnRH antagonists trial data for the treatment of endometriosis.

Sawsan As-Sanie, MD, Jessica Shim, MD, Robert Taylor, MD, PhD, and Linda Giudice, MD, PhD, discuss the multidisciplinary approach and shared decision-making strategies associated with endometriosis treatment.

Hugh Taylor, MD, along with a panel of experts, discuss the different challenges of diagnosing endometriosis as well as explaining why there is commonly a delay in diagnosis.

A panel of experts provide an overview of the health complications that are associated with endometriosis.

Sawsan As-Sanie, MD, Jessica Shim, MD, Robert Taylor, MD, PhD, and Linda Giudice, MD, PhD, discuss the 3 main types of endometriosis and the commonly associated symptoms and risk factors.

Hugh Taylor, MD, leads a discussion with a panel of experts about the prevalence of endometriosis.

Researchers from the Feinstein Institute in Manhasset, New York, found single-cell RNA sequencing to be an effective and noninvasive way to screen for and diagnose patients with endometriosis.

Myovant Sciences and Pfizer announces the US Food and Drug Administration has approved Myfembree (relugolix combination tablets) for the once-daily treatment of moderate-to-severe endometriosis-associated pain.

Women with endometriosis had a 34% greater risk of stroke than women without the chronic inflammatory gynecological condition, according to an analysis of the Nurses Health Study II.

A review of magnetic resonance imaging (MRI) for diagnosing endometriosis and related diseases in the Korean Journal of Radiology has found that the medical imaging technique can help in the early and accurate diagnosis of ovarian endometriotic cysts and deep infiltrating endometriosis (DIE), while avoiding the need for invasive procedures and radiation exposure, due to MRI’s high contrast and objectivity.

Most studies conclude that dietary interventions positively impact endometriosis, according to a systematic review in the journal Reproductive Sciences.

A study published in Cannabis and Cannabinoid Research found that women often used cannabis to manage endometriosis symptoms during the COVID-19 pandemic.

Rates of endometriosis are generally higher in leaner women, yet there still seems to be a connection between the presence and placement of fat tissue and the development of endometriosis. One study team sought to find out why.

A preprogrammed, nomad, easy-to-use, transcutaneous electrical nerve stimulation (TENS) device was well tolerated and provided rapid and lasting pain decrease in women with primary dysmenorrhea (PD), according to a study published in the journal Progrés en Urologie.

A study published in the Journal of Clinical Medicine highlights the high burden of endometriosis, including infertility, comorbidities, health care usage, and medical costs.

An expert reproductive endocrinologist explores the future treatment landscape for patients with endometriosis.